Home Beauty Health FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said

on November 02, 2021
FDA weighs new COVID antibody drug that could be 'holy grail' for immunocompromised: AZD7442 showed 77% efficacy, AstraZeneca said submitted by /u/shallah
[link] [comments]


from Health https://ift.tt/3k37kee
,
Share To:

Unknown

View Profile

Post A Comment:

0 comments so far,add yours

Subscribe to: Post Comments (Atom)